Abstract
We screened 868 marine extracts in search of hematopoietic molecules resulted in findings of several extracts that proliferated Ba/F3-HuMpl cells but not the cells expressed with other hematopoietic cytokine receptors, EPO and G-CSF. Separation of the most potent extract of a Micronesian sponge Corticium sp., guided by the cell proliferation assay using Ba/F3-HuMpl cells resulted in an isolation of thrombocorticin (ThC), a novel 14 kDa protein as an active principal. ThC displayed concentration-dependent proliferation of Ba/F3-HuMpl cells, and had a stronger activity than that of eltrombopag, a small molecule drug used to treat thrombocytopenia. ThC induced phosphorylation of STAT5, suggesting that it activates Jak/STAT pathway as in the case of TPO. These results together indicated that ThC is a specific agonist for c-Mpl, although the size and shape differs largely from TPO. Here we present isolation, characterization and biological activity of ThC.
Author supplied keywords
Cite
CITATION STYLE
Watari, H., Nakajima, H., Atsuumi, W., Nakamura, T., Nanya, T., Ise, Y., & Sakai, R. (2019). A novel sponge-derived protein thrombocorticin is a new agonist for thrombopoietin receptor. Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology, 221, 82–88. https://doi.org/10.1016/j.cbpc.2019.04.003
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.